Technical internships at ChEMBL

Technical internships at ChEMBL.

We are looking for skilled Computer Science (and related fields) students with strong programming skills to join our team for 3-6 month internships. This is not necessarily a summer internship program, you can start whenever convenient for you after being accepted. Please take a look at some of the research ideas / candidate profiles below:

1. Java programmer - we are looking for a person with experience in Java to develop a prototype of new KNIME nodes for interacting with the ChEMBL API. Experience with REST and/or KNIME is a plus but not a requirement - you can learn it during your internship. A very important thing to note that you should be excited about UX and creating user-friendly and pragmatic GUIs.

2. C++ programmer - we would like to invite a person passionate about C++ and pattern recognition / image processing to experiment with optimising the open-source OSRA code. OSRA is like OCR but for molecules. We want to make it faster and more accurate.

3. C++ programmer with a graph theory knowledge. Chemical compounds are represented as graphs in-silico. We want to be able to quickly generate random graphs that would also be valid compounds. Experience with distributed computing, computing grids, network file systems and map-reduce is a plus but not required.

4. JavaScript programmer - "any application that can be written in JavaScript, will eventually be written in JavaScript". This is why we are looking for a person with JS experience to experiment with:

Creating prototypes of reusable chemical web widgets using polymer.
Using emscripten to cross compile some core chemical software written in C++ to JS.

5. A person with a data visualisation skills to explore Kibana and Kibi tools to create beautiful and informative datavis widgets from ChEMBL data.

6. Someone with the Natural Language Processing background to:

Create a dictionary of common spelling mistakes in chemistry patents.
Create a network of patent relations using textrank algorithm.
Explore different approaches to the Named Entity Classification problem.

How to apply?

Just send your CV to kholmes @ ebi.ac.uk with 'ChEMBL Tech Internships' subject.

When to apply?

You can apply anytime but we will only contact selected candidates.

Will all those internships start at the same time?

No, in fact we are planning to select max. 2 most interesting candidates at a given time.

Will I get paid?

The internship is paid 800 GBP per month OR funded by your alma mater (whatever is better for you).

Comments

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and here for a reminder of SureChEMBL is and what it does. This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

The ChEMBL-og

Search This Blog